News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

News

Genetic Diagnostic for Type 2 Diabetes

New Research Findings, Computational Health, ITG,

Big Data Make Hidden Genetic Drivers of Type 2 Diabetes Visible

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D) – but which genes and proteins are actually involved in the disease mechanisms? An international team led by Helmholtz Munich has now used globally collected…

HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, HI-MAG,

Cholesterol-Lowering Drug Found to Target Key Metabolic Switch

Cardiovascular diseases are the leading cause of death worldwide, and lowering blood lipids is a central strategy to reduce risk. Bempedoic acid, a recently approved cholesterol-lowering drug, has now been shown by researchers at Helmholtz Munich to…

Healthy gut bacteria concept with natural probiotics for immune support.

New Research Findings, Molecular Targets and Therapeutics, INET,

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

New Research Findings, Bioengineering, IBMI,

New Imaging Technology Detects Early Signs of Heart Disease Through the Skin

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

Big data technology data science analysis

AI, New Research Findings, Computational Health, ICB,

BioPathNet: New AI Uncovers Hidden Patterns in Biomedical Knowledge Graphs

A new artificial intelligence (AI) method called BioPathNet helps researchers systematically search large biological data networks for hidden connections – from gene functions and disease mechanisms to potential therapeutic approaches. BioPathNet was…

Maria Keller mit einer Kollegin im Labor

Awards & Grants, Diabetes, HI-MAG,

Adipose Tissue Under the Microscope: Funding for Two Metabolic Health Projects

Dr. habil. Maria Keller, team leader at the Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG), an institute of Helmholtz Munich at the University of Leipzig and University of Leipzig Medical Center, has successfully secured…

People & Grants

Sandra Hummel 1

Awards & Grants, Diabetes, IDF,

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

Neuron in action

Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Maria Keller mit einer Kollegin im Labor

Awards & Grants, Diabetes, HI-MAG,

Adipose Tissue Under the Microscope: Funding for Two Metabolic Health Projects

Dr. habil. Maria Keller, team leader at the Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG), an institute of Helmholtz Munich at the University of Leipzig and University of Leipzig Medical Center, has successfully secured…

Press Contact

COMS Communications & Strategic Relations

+49 89 3187 49342

pressespam prevention@helmholtz-munich.de